WILLOW SPRINGS, Ill. (WGN) — There has been an extraordinary step forward in the treatment of spinal cord injuries. For the patients who come through the door of the Next Steps clinic in southwest ...

A recent review published in Engineering explores the construction and potential applications of spinal cord and peripheral nerve organoids for regenerative medicine in neurotrauma. The article, ...

Over the past decade, advances in techniques to stimulate the spinal cord with implanted electrodes have shown enormous potential, restoring one's ability to stand and walk even when the spinal cord ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial. It's a ...

Spinal cord injuries are currently incurable with devastating effects on people's lives, but now a trial at Waipapa Taumata Rau, University of Auckland offers hope for an effective treatment. Spinal ...

Clinicians have long treated spinal cord injuries—a leading cause of long-term disability—in part by augmenting a patient’s blood pressure. The idea was that the injury impacted the body’s regulation ...

A Phase 1 human clinical trial to treat chronic spinal cord injury, the first of its kind in the world, has commenced to test the efficacy and safety of a revolutionary new treatment using nasal cells ...

ATLANTA — The Shepherd Center in Buckhead, Atlanta, is celebrating its 50th anniversary, marking five decades of transforming lives through specialized rehabilitation for brain and spinal cord ...

Chicago-based Amphix Bio has raised $12.5 million in seed funding to advance its experimental paralysis-reversing drug toward human trials, the Northwestern University spinout announced today. The ...